MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a privately held biopharmaceutical company, announced today the appointment of Dr. Andrew Pecora, FACP, as Chairman of the Board. Dr. Pecora had served as a member of the Company’s Board of Directors since January 2007.
